EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $782 | +0.3% | 27,562 | +3.3% | 0.02% | 0.0% |
Q4 2022 | $780 | -99.9% | 26,675 | +24.2% | 0.02% | +21.4% |
Q3 2022 | $567,000 | -40.6% | 21,475 | 0.0% | 0.01% | -36.4% |
Q2 2022 | $954,000 | -78.9% | 21,475 | -76.5% | 0.02% | -75.6% |
Q1 2022 | $4,530,000 | -20.9% | 91,534 | -18.7% | 0.09% | -6.2% |
Q4 2021 | $5,730,000 | -6.3% | 112,534 | +2.7% | 0.10% | -12.7% |
Q3 2021 | $6,114,000 | +157.0% | 109,604 | +97.2% | 0.11% | +161.9% |
Q2 2021 | $2,379,000 | – | 55,594 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |